Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

46.5K
Overview
46.5K
Cancer Vaccines01:30

Cancer Vaccines

568
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
568
Cross-reactivity00:42

Cross-reactivity

31.8K
Overview
31.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of Allplex HPV HR Detection Full Genotyping Assay on Cervical Samples Compared to Vaginal Self-Samples.

Journal of medical virology·2026
Same author

Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource Settings.

International journal of cancer·2026
Same author

Towards elimination of viral hepatitis in the Czech Republic, Hungary, Poland and Slovakia: insights from the Viral Hepatitis Prevention Board (VHPB).

Clinical and experimental hepatology·2026
Same author

Evaluating DNA methylation markers and extended HPV genotyping in first-void urine for detecting high-grade cervical lesions in HPV-positive women: a cross-sectional study.

BMC medicine·2026
Same author

Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.

Communications medicine·2026
Same author

Advancing Vaccination Strategies for Older Adults: Insights of the Adult Immunization Board Meeting.

Drugs & aging·2026

Related Experiment Video

Updated: Oct 18, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.9K

Hepatitis B Vaccines.

Jade Pattyn1, Greet Hendrickx1, Alex Vorsters1

  • 1Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium.

The Journal of Infectious Diseases
|September 30, 2021
PubMed
Summary
This summary is machine-generated.

Hepatitis B vaccines are highly effective, significantly reducing liver disease and cancer worldwide. Global vaccination coverage has increased dramatically, controlling the spread of the hepatitis B virus (HBV).

Keywords:
hepatitis Bhepatitis B vaccinationhepatitis B virus

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.4K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.5K

Related Experiment Videos

Last Updated: Oct 18, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.9K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.4K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.5K

Area of Science:

  • Hepatology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis B virus (HBV) infection is a major global health concern, leading to severe liver conditions like cirrhosis and liver cancer.
  • HBV causes significant worldwide morbidity and mortality.
  • Hepatitis B vaccines are crucial for controlling and preventing HBV infection.

Purpose of the Study:

  • To summarize the successes of the hepatitis B vaccine, the first virus-like particle and anticancer vaccine.
  • To discuss current challenges and future directions in hepatitis B vaccination strategies for global HBV prevention.

Main Methods:

  • Review of global hepatitis B vaccination coverage data from 2000 to 2019.
  • Analysis of the impact of vaccination programs on HBV carrier rates and disease burden.
  • Discussion of vaccine development and public health implementation.

Main Results:

  • Hepatitis B vaccine coverage increased from approximately 30% in 2000 to 85% worldwide in 2019.
  • Effective vaccination programs have led to a significant reduction in HBV carrier rates.
  • Substantial decreases in hepatitis B-related morbidity and mortality have been observed globally.

Conclusions:

  • The hepatitis B vaccine represents a major public health triumph, significantly reducing disease and mortality.
  • Continued efforts and future strategies are necessary to achieve global eradication of HBV infection.
  • The vaccine's success highlights the potential of virus-like particle-based vaccines in cancer prevention.